| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 794 | 2019 |
| The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor P Ciana, M Fumagalli, ML Trincavelli, C Verderio, P Rosa, D Lecca, ... The EMBO journal 25 (19), 4615-4627, 2006 | 517 | 2006 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 495 | 2021 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 314 | 2017 |
| The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair D Lecca, ML Trincavelli, P Gelosa, L Sironi, P Ciana, M Fumagalli, G Villa, ... PloS one 3 (10), e3579, 2008 | 262 | 2008 |
| Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation M Fumagalli, S Daniele, D Lecca, PR Lee, C Parravicini, RD Fields, ... Journal of Biological Chemistry 286 (12), 10593-10604, 2011 | 204 | 2011 |
| The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, AA Mathie, ... British Journal of Pharmacology 180, S23-S144, 2023 | 153 | 2023 |
| Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y13 receptor M Fumagalli, L Trincavelli, D Lecca, C Martini, P Ciana, MP Abbracchio Biochemical pharmacology 68 (1), 113-124, 2004 | 144 | 2004 |
| Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases M Fumagalli, D Lecca, MP Abbracchio, S Ceruti Frontiers in pharmacology 8, 941, 2017 | 122 | 2017 |
| Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation D Lecca, S Ceruti Biochemical pharmacology 75 (10), 1869-1881, 2008 | 117 | 2008 |
| Frontal affinity chromatography− Mass Spectrometry useful for characterization of new ligands for GPR17 receptor E Calleri, S Ceruti, G Cristalli, C Martini, C Temporini, C Parravicini, ... American Chemical Society, 2010 | 92 | 2010 |
| CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17 M Fumagalli, D Lecca, MP Abbracchio Neuropharmacology 104, 82-93, 2016 | 91 | 2016 |
| Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor P Gelosa, D Lecca, M Fumagalli, D Wypych, A Pignieri, M Cimino, ... Journal of Cerebral Blood Flow & Metabolism 34 (6), 979-988, 2014 | 90 | 2014 |
| Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPγS binding and electrophysiological studies in 1321N1 cells AM Pugliese, ML Trincavelli, D Lecca, E Coppi, M Fumagalli, S Ferrario, ... American Journal of Physiology-Cell Physiology 297 (4), C1028-C1040, 2009 | 78 | 2009 |
| Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury H Franke, C Parravicini, D Lecca, ER Zanier, C Heine, K Bremicker, ... Purinergic signalling 9, 451-462, 2013 | 73 | 2013 |
| MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis D Lecca, D Marangon, GT Coppolino, AM Méndez, A Finardi, GD Costa, ... Scientific reports 6 (1), 34503, 2016 | 69 | 2016 |
| Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17 S Daniele, D Lecca, ML Trincavelli, O Ciampi, MP Abbracchio, C Martini Cellular signalling 22 (4), 697-706, 2010 | 63 | 2010 |
| Regulation of oligodendrocyte functions: targeting lipid metabolism and extracellular matrix for myelin repair D Marangon, M Boccazzi, D Lecca, M Fumagalli Journal of clinical medicine 9 (2), 470, 2020 | 60 | 2020 |
| Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death D Lecca, S Ceruti, M Fumagalli, MP Abbracchio Purinergic signalling 8, 539-557, 2012 | 54 | 2012 |
| The ubiquitin ligase M dm2 controls oligodendrocyte maturation by intertwining m TOR with G protein‐coupled receptor kinase 2 in the regulation of GPR 17 receptor desensitization M Fumagalli, E Bonfanti, S Daniele, E Zappelli, D Lecca, C Martini, ... Glia 63 (12), 2327-2339, 2015 | 51 | 2015 |
Rosa PResearch director, CNRVerified email at in.cnr.it
